The use of ITS DNA sequence analysis and MALDI-TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum.
Although mycoses are among the most common diseases worldwide, infections with Fusarium spp. occur only rarely. Mostly patients suffering from underlying immune deficiency are infected with this mould, resulting in a considerably decreasing prognosis. In immunocompromised patients, cutaneous manifestations are more often associated with Fusarium sp. than with Candida sp. or Aspergillus sp. We describe one patient with acute lymphoblastic leukaemia, who was first treated with chemotherapy after GMALL protocol 07/03. After relapse, the patient was successfully transplanted in second remission with a human leukocyte antigen (HLA)-matched unrelated peripheral blood stem cell graft. Ten months later, the patient died from respiratory insufficiency and recurrence of leukaemia. Previously, Aspergillus antigen was detected in blood. In the latter course, disseminated papules appeared. One of these was examined histologically and mycologically. Conventional cultural diagnostics led to the diagnosis of a fusariosis, further supported by internal transcribed spacer (ITS) sequencing and matrix assisted laser desorption/ionisation-time-of-flight mass spectrometry (MALDI-TOF) mass spectrometry, both determining the isolated strain as Fusarium proliferatum, which is a very infrequent pathogen within this genus. Our investigations underline the potential of MALDI-TOF MS based identification of Fusarium species as an innovative, time and cost efficient alternative to ITS sequencing.
Klinik für Dermatologie und Dermatologische Allergologie, Universitätsklinikum Jena, Jena, Germany. florian.seyfarth@med.uni-jena.de
Florian
F
Seyfarth
Mirjana
M
Ziemer
Herbert G
HG
Sayer
Anke
A
Burmester
Marcel
M
Erhard
Martin
M
Welker
Sibylle
S
Schliemann
Eberhard
E
Straube
Uta-Christina
UC
Hipler
D000328:Adult; D021903:DNA, Ribosomal Spacer / Q000737:chemistry / Q000235:genetics*; D017809:Fatal Outcome; D005260:Female; D005670:Fusarium / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D010802:Phylogeny; D012340:RNA, Ribosomal, 5.8S / Q000235:genetics; D017422:Sequence Analysis, DNA / Q000379:methods*; D012867:Skin / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*
D021903:DNA, Ribosomal Spacer; D012340:RNA, Ribosomal, 5.8S